Peripheral Vascular Devices Market By Product Type (Stents {Balloon Angioplasty Stents, Covered Stents, Drug-Eluting Stents}, Catheters{Guide Catheters, Balloon Catheters, Sheath Catheters}, Angioplasty Balloons, Vascular Grafts, Guidewires, Inferior Vena Cava Filters, Other), By Indication (Peripheral Artery Disease, Aortic Aneurysm, Dialysis Access, Carotid Artery Disease, Other ), By Technology (Bare Metal Stents, Drug-Eluting Stents, Covered Stents, Balloon Angioplasty, Endovenous Laser Therapy, Cryoplasty, Biodegradable Stents, Infrared Therapy), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others ), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Peripheral Vascular Devices market accounted for USD 10.8 Billion in 2024 and is expected to reach USD 21.6 Billion by 2035, growing at a CAGR of around 6.5% between 2025 and 2035. Peripheral Vascular Devices Market includes medical instruments that are used to diagnose, treat, and manage conditions affecting the vessels outside the heart and the brain or the peripheral vessels in limbs and other body parts. These devices are used to treat peripheral artery disease (PAD), aortic aneurysms, and carotid artery diseases, which are characterized by blockage, constriction, or injury to arteries.

Peripheral vascular devices may consist of devices such as stents, catheters, angioplasty balloons, guidewires, vascular grafts, and inferior vena cava (IVC) filters. Their principal purpose is to recanalize the vessels and prevent obstruction or formation of clots; this makes it possible to perform less invasive interventions that promote vascular health.

Report Scope:

Market Dynamics

The rising prevalence of peripheral artery disease drives demand for advanced devices.

With the growing number of individuals suffering from peripheral arterial disease (PAD), the peripheral vascular devices market has enormous potential. PAD causes pain and fatigue by obstructing blood flow to the limbs due to fatty deposits in the arteries. In the worst situations, the afflicted limbs must be amputated or removed medically. This is because smoking, eating badly, and not exercising increase the risk of PAD, and the world's population is growing. This has made the creation of fresh, efficient technologies for the condition's administration and treatment necessary. Because PAD has a significant influence on quality of life, less invasive therapies, including angioplasty, stent insertion, and atherectomy, are becoming more and more required. Device advances like drug-eluting stents, balloons, and catheters can help achieve these less invasive therapies.

The growing adoption of minimally invasive procedures boosts peripheral device utilization globally.

Technological advancement in the use of minimally invasive surgeries is driving the peripheral vascular devices market. Less invasive surgery that includes intricate procedures like angioplasty, stents, and atherectomy can be used to repair coronary vessels. Medical devices, including drug-eluting stents, balloons, and guidewires, have become more popular as patients choose less invasive treatments since they are less risky and need less time to recover and rehabilitate.

Catheter-based procedures, robotic technologies for surgical support, and other emerging imaging technologies are becoming more accurate and efficient, which can enhance their use. As access to healthcare and patient awareness grow, the natural trend toward less invasive procedures is not just driving the adoption of peripheral vascular devices in developed regions but also in emerging economies.

High costs of advanced peripheral vascular devices limit widespread adoption.

Peripheral vascular devices' high cost limits their accessibility, particularly in developing nations or in healthcare facilities with limited funding, which significantly limits their use and slows Peripheral Vascular Devices Market expansion. Due to their high initial expenses of use, many patients find it impossible to obtain imaging systems such as drug-eluting stents, bioresorbable scaffolds, specific diplomat wires, etc. By expanding the mapping of financial duties, the length of the hospitalized patient's stay, diagnostic testing, and follow-up care, the overall cost of the least invasive procedures is calculated. Cost-effective solutions can therefore be chosen, which may limit the use of suitable, contemporary innovations. To make these devices more inexpensive and available to a greater number of patients, companies are working harder to reduce the cost of manufacturing them. They are also addressing insurance coverage and offering a new pricing model based on values.

Expanding healthcare infrastructure in developing countries fuels market penetration opportunities.

The growth of infrastructure in developing countries is a major factor that provides a significant opportunity for the Peripheral Vascular Devices Market. The need for improved technologies to treat PAD and other vascular disorders is growing in these areas as a result of changes in healthcare systems and economic reasons. Advanced medical devices, including stents, catheters, and angioplasty balloons, can more easily reach the patient population due to the government's assistance in the modernization of the healthcare infrastructure and the opening of new, contemporary hospitals and clinics. Improving healthcare delivery to these areas is becoming more and more important, and the outcomes are made possible by the use of technology for minimally invasive operations. With the increase in knowledge of the public and medical communities regarding vascular disorders, the need for accurate diagnostics and therapeutic strategies also increases. This means that market players have a chance of increasing their market share and offering emerging markets better, improved, and cheaper gadgets.

Emerging innovations in drug-coated balloons offer potential for market expansion.

Peripheral vascular devices and newer technologies like drug coating on balloons (DCBs) are anticipated to have enormous opportunities for the Peripheral Vascular Devices Market. These balloons have a layer of drugs that reduces the tendency of arteries to re-narrow after interventions, particularly after procedures such as angioplasty, better than standard balloons.

The potential to provide medication therapy only to the necessary area while simultaneously preventing restenosis is the key concept employed here. DCBs are being employed extensively in the treatment of conditions like femoral artery blockages and peripheral artery disease (PAD) because of the coatings' improved accuracy. It improves the efficacy of conventional devices but also treats such pathologies as complex lesions and smaller vessels, which used to be challenging.

Industry Experts Opinion

“These next-generation technologies allow physicians to treat larger, more difficult vessels through smaller delivery options. It is yet another way Terumo is providing the opportunity for operators to take advantage of the benefits of radial access for increasingly complex procedures while enhancing therapeutic options in the peripheral vasculature with a microvascular plug. It is a welcome addition to our innovative, best-in-class portfolio.”

• Michael Martinelli, MD, Chief Medical Officer, Terumo Medical Corporation

“Shockwave’s new peripheral catheter offers remarkable improvements that enable efficient and effective treatment for some of our most difficult-to-treat patients, some of whom previously could not have been treated with IVL.”

• Peter Soukas, Miriam and Rhode Island Hospitals, Providence, USA

Segment Analysis

Based on product type, the Peripheral Vascular Devices Market has been classified as stents, catheters, angioplasty balloons, vascular grafts, guidewires, and IVC filters. The stent segment, especially drug-eluting stents (DES) and covered stents make a major contribution because they are used to treat PAD (peripheral artery disease). It is established that factors such as the rising incidence of vascular diseases and demand for non-invasive interventions are leading to the advance in this market. Drug-eluting stents, which reduce the risk of restenosis, are particularly favored, prompting the expansion of coating technologies.

Based on Indication, the Peripheral Vascular Devices Market is divided into peripheral artery diseases like aneurysms, dialysis, and carotid artery diseases. The increase in nutritional hazards, such as obesity, diabetes, and smoking, which result in a higher number of arterial blockages, has given the PAD category the largest market share at the moment. The market is further supported by the latest developments in drug-coated balloons and minimally invasive techniques providing an ideal solution set for PAD. The segment covering aortic aneurysms is expanding based on early diagnostic solutions and technologies that increase the treatment rate.

Regional Analysis

The North Peripheral Vascular Devices Market is rapidly expanding due to the higher incidences of peripheral artery disease (PAD), the developed healthcare sector, and better technical awareness. The region is densely populated with important players who continue to diversify and improve their goods, such as Abbott, Boston Scientific, and Medtronic. DCBs and BRS are recent developments in the field that improve treatment outcomes for PAD patients. Furthermore, North America places a strong emphasis on various peripheral vascular devices, such as minimally invasive techniques and sophisticated imaging methods.

Asia Pacific Peripheral Vascular Devices Market is growing rapidly due to factors including social and economic development in the region, enhanced healthcare system, and awareness of vascular diseases. There have been constant increases in investments in healthcare facilities and the need to provide the best medical technologies and equipment. The latest developments in the Asia Pacific consist of advanced atherectomy technologies and new thrombectomy systems to improve patients' benefit-risk ratio during procedures. Likewise, with the instant shift to mobile health care and telemedicine solutions, the vascular care market in emerging markets such as China, India, and Japan is challenging to ignore.

Competitive Landscape

The peripheral Vascular Devices Market is highly competitive, with key players such as Medtronic, Boston Scientific, Abbott, B. Braun, and Terumo actively contributing toward product portfolio expansion, geographical expansion, and mergers and acquisitions. Although most of these companies are offering some kinds of stents and drug-coated technology, they differ in their focus; Medtronic and Boston Scientific, for instance, offer the latest improved stent technologies; on the other hand, Abbott has specialized in imaging systems and bioresorbable scaffolds.

The objectives of Terumo are to focus on high-growth regions primarily in the APEC and expand its product portfolio. The latest technologies, such as drug-coated balloons, image-guided systems, and the bioresorbable vascular scaffold, are driving competition while defining the market with new, safer, and more effective vascular solutions.

Many companies are spending their money on personalized approaches, radial nerve release, ultrasound and computer-aided imagery, and even artificial intelligence. Specified M&As specifically increase product portfolios and position in the market, as seen in the Boston Scientific BTG case. These biotech and therapeutic delivery improvements provide additional market advantages to players in this rapidly advancing industry.

Peripheral Vascular Devices Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In November 2024, Medtronic announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions. The Total REALITY study retrospectively compared directional atherectomy (DA) versus balloon dilatation before drug-coated balloon (DCB) treatment of long, calcified femoropopliteal lesions.

 

• In September 2024, Shockwave Medical, Inc., part of Johnson & Johnson MedTech and a global leader in the field of circulatory restoration, announced the full U.S. launch of the Shockwave E⁸ Peripheral IVL Catheter, following clearance by the U.S. Food and Drug Administration (FDA). The Shockwave E⁸ catheter is designed to optimize the treatment of patients with calcified femoropopliteal and below-the-knee peripheral artery disease (PAD), including patients with complex chronic limb-threatening ischemia (CLTI).  

Report Coverage:

   By Product Type:

• Stents
  • Balloon Angioplasty Stents
  • Covered Stents
  • Drug-eluting stents (DES)
• Catheters
  • Guide Catheters
  • Balloon Catheters
  • Sheath Catheters
• Angioplasty Balloons
• Vascular Grafts
• Guidewires
• Inferior Vena Cava (IVC) Filters
• Other

By Indication:

• Peripheral Artery Disease (PAD)
• Aortic Aneurysm
• Dialysis Access
• Carotid Artery Disease
• Other

By Technology:

• Bare Metal Stents (BMS)
• Covered Stents
• Balloon Angioplasty
• Endovenous Laser Therapy (EVLT)
• Cryoplasty
• Biodegradable Stents
• Infrared Therapy

By End-User:

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• B. Braun Melsungen AG
• Terumo Corporation
• Cardinal Health, Inc.
• Cook Medical
• AngioDynamics, Inc.
• Endologix LLC
• Becton, Dickinson and Company
• Teleflex Incorporated
• iVascular SLU
• Spectranetics Corporation
• W. L. Gore & Associates, Inc.
• Medinol Ltd.
• Cordis Corporation
• CryoLife, Inc.
• Biotronik SE & Co. KG

Frequently Asked Questions (FAQs)